Broader Medicaid eligibility, gradual tapering of cost-sharing assistance, and increased transparency in drug pricing are proposed policy solutions to reduce these barriers [137], but new legislation is expected to further depress the availability of beneficial drugs, including GLP-1R agonists, reversing attempts to optimize care for those in greatest need [138]
The terms may be synonyms of the code title, or, in the case of "other specified" codes, the terms are a list of the various conditions assigned to that code
They can treat much more than just diabetes or obesity
And I cant really sugar coat this at all
Zubair, S., Hafeez, S., & Mujtaba, G